Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Maritza Loinaz

Orthopaedic Surgery Bayamon, PR Medical Doctor

NPI 1629183637 CMS profile 1121551

Calle J Edificio Medico Hermanas Davila, Suite #206 Urb Villa Rica, Bayamon, PR 00959

Open in the dashboard

General payments

$763

10 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Maritza Loinaz of Bayamon, PR is reported in the CMS Open Payments database as having received $763 across 10 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 26th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $417 4
2022 General $94 1
2019 General $252 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Maritza Loinaz
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Maritza Loinaz were reported at $0. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Maritza Loinaz Orthopaedic Surgery median Middle half National median
2019 $252 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $94 $598 $128–$2,731 $149
2023 $0 $461 $128–$2,264 $160
2024 $417 $497 $134–$2,475 $164
2025 $0 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Encore Medical, LP $238 2 payments
  2. Janssen Pharmaceuticals, Inc $194 2 payments
  3. Smith+Nephew, Inc. $180 2 payments
  4. Johnson and Johnson International $120 2 payments
  5. Ferring Pharmaceuticals Inc. $32 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $702 9 payments
  2. Travel and Lodging $61 1 payment
Products named General payments · program years 2019–2024
  1. XARELTO $194 2 payments
  2. REAL INTELLIGENCE $180 2 payments
  3. DJO SURGICAL Joint Implants $177 1 payment
  4. DJO SURGICAL Joint Implants $177 1 payment
  5. HARMONIC Product Family $120 2 payments
  6. EVICEL $120 2 payments
  7. STRATAFIX $107 1 payment
  8. DJO SURGICAL Joint Implants $61 1 payment
  9. DJO SURGICAL Joint Implants $61 1 payment
  10. EUFLEXXA $32 2 payments
  11. Other $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

1,316

Median for Orthopedic Surgery: 203

Drug cost

$28,071

Median for Orthopedic Surgery: $1,433

Branded share of claims

11.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Potassium Generic 395 $15,239
Acetaminophen-Codeine Acetaminophen With Codeine Brand 99 $2,625
Diclofenac Sodium Generic 123 $1,833
Gabapentin Generic 91 $1,494
Triamcinolone Acetonide Generic 114 $1,475
Tramadol Hcl Generic 173 $1,033
Methylprednisolone Generic 61 $700
Celecoxib Generic 22 $681
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 27 $602
Levofloxacin Generic 72 $577

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$31,797

Medicare's payments for the services billed

Medicare patients

27

Average age 82

Services billed

141

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 56%
Arthritis 56%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

10 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record